GlassScriptPhysician profile
Mathew S Isho
NPI 1841235645
$19,087.45
in general payments reported to CMS, 2019-2025
24 companies · $83.89 in 2025
The $83.89 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $951 · 2020: $4,212 · 2021: $606 · 2022: $3,804 · 2023: $2,815 · 2024: $6,616 · 2025: $83.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,406 · Education: $4,000 · Food and Beverage: $743 · Travel and Lodging: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,406.26 |
| Education | $4,000.00 |
| Food and Beverage | $742.89 |
| Travel and Lodging | $365.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,260.37 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $4,406.26 | 2023-2024 | |
| Applied Medical Resources Corporation | $3,520.57 | 2022 | |
| Davol INC. | $527.30 | 2021-2025 | Phasix Mesh |
| Kerecis Limited | $170.61 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ethicon US, LLC | $160.20 | 2019-2024 | Ethicon, Harmonic, Stratafix |
| Acera Surgical, INC. | $142.53 | 2023 | Restrata Wound Matrix |
| Biotissue Holdings INC. | $133.89 | 2024-2025 | |
| Boston Scientific Corporation | $122.72 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $117.15 | 2019-2023 | Clenpiq |
| Prescient Surgical | $110.03 | 2019 | |
| Aroa Biosurgery Incorporated | $88.13 | 2023-2024 | |
| Coloplast Corp | $57.47 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $39.64 | 2022 | |
| Histosonics, INC. | $35.07 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $30.18 | 2019-2020 | |
| Organogenesis INC. | $26.28 | 2023 | Puraply |
| Integra Lifesciences Corporation | $24.84 | 2021 | |
| Reprise Biomedical, INC. | $23.22 | 2023 | Miro3d |
| Braintree Laboratories, INC. | $22.96 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.25 | 2021 | |
| Convatec INC. | $16.79 | 2020 | |
| Stryker Corporation | $16.21 | 2022 | |
| Conmed Corporation | $14.78 | 2025 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Isho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.